IMRN
Immuron Ltd ADR
NASDAQ: IMRN · HEALTHCARE · BIOTECHNOLOGY
$0.82
+1.86% today
Updated 2026-04-30
Market cap
$7.11M
P/E ratio
—
P/S ratio
0.95x
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$1 – $2
Volume
0.0M
Immuron Ltd ADR (IMRN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |